Advances in gene therapy are yielding new options for treating inherited retinal degenerations, giving specialists new tools — and new hope for patients and families.

A Cas9 protein discovered in meningitis bacteria can act as precise “scissors” for both types of genetic material, cutting at a desired spot guided by CRISPR RNAs.